Alkaloids/pharmacology; Animals; Antineoplastic Agents/pharmacology; Base Sequence; DNA Footprinting; DNA Topoisomerases, Type II/antagonists & inhibitors; DNA, Neoplasm/drug effects; Dose-Response Relationship, Drug; Indole Alkaloids; Indoles; Intercalating Agents/pharmacology; Melanoma, Experimental/metabolism; Mice; Molecular Sequence Data; Nucleic Acid Denaturation/drug effects; Quinolines; Spectrum Analysis
Abstract :
[en] Cryptolepine hydrochloride is an indoloquinoline alkaloid isolated from the roots of Cryptolepis sanguinolenta. It is characterized by a multiplicity of host-mediated biological activities, including antibacterial, antiviral, and antimalarial properties. To date, the molecular basis for its diverse biological effects remains largely uncertain. Several lines of evidence strongly suggest that DNA might correspond to its principal cellular target. Consequently, we studied the strength and mode of binding to DNA of cryptolepine by means of absorption, fluorescence, circular, and linear dichroism, as well as by a relaxation assay using DNA topoisomerases. The results of various optical and gel electrophoresis techniques converge to reveal that the alkaloid binds tightly to DNA and behaves as a typical intercalating agent. In DNAase I footprinting experiments it was found that the drug interacts preferentially with GC-rich sequences and discriminates against homo-oligomeric runs of A and T. This study has also led to the discovery that cryptolepine is a potent topoisomerase II inhibitor and a promising antitumor agent. It stabilizes topoisomerase II-DNA covalent complexes and stimulates the cutting of DNA at a subset of preexisting topoisomerase II cleavage sites. Taking advantage of the fluorescence of the indoloquinoline chromophore, fluorescence microscopy was used to map cellular uptake of the drug. Cryptolepine easily crosses the cell membranes and accumulates selectively into the nuclei rather than in the cytoplasm of B16 melanoma cells. Quantitative analyses of DNA in cells after Feulgen reaction and image cytometry reveal that the drug blocks the cell cycle in G2/M phases. It is also shown that the alkaloid is more potent at inhibiting DNA synthesis rather than RNA and protein synthesis. Altogether, the results provide direct evidence that DNA is the primary target of cryptolepine and suggest that this alkaloid is a valid candidate for the development of tumor active compounds.
De Pauw-Gillet, Marie-Claire ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Histologie - Cytologie - Département des sciences biomédicales et précliniques
Defresne, Marie-Paule ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Histologie - Cytologie
Colson, Pierre ; Université de Liège - ULiège > Département de chimie (sciences) > Département de chimie (sciences)
Houssier, Claude ; Université de Liège - ULiège > Services généraux (Faculté des sciences) > Relations académiques et scientifiques (Sciences)
Dassonneville, L.
Bailly, Claude; Université de Liège - ULiège
Greimers, Roland ; Centre Hospitalier Universitaire de Liège - CHU > Anatomie pathologique
Clinquart, E. D. (1929) Bull. Acad. R. Méd. 9, 627-635.
Delvaux, E. (1931) J. Pharm. Belg. 13, 955-959.
Gellert, E., Raymond-Hamet, and Schlittler, E. (1951) Helv. Chim. Acta 34, 642-651.
Dwuma-Badu, D., Ayim, S. K., Fiagbe, N. I. Y., Knapp, J. E., Schiff, Jr., P. L., and Slatkin, D. J. (1978) J. Pharm. Sci. 67, 433-434.
Ablordeppey, S. A., Hufford, C. H., Borne, R. F., and Dwuma-Badu, D. (1990) Planta Med. 56, 416-417.
Tackie, A. N., Sharaf, M. H. M., Schiff, P. L., Jr., Boye, G. L., Crouch, R. C., and Martin, G. E. (1991) J. Heterocycl. Chem. 28, 1429-1435.
Gunatilaka, A. A. L., Sotheeswaran, S., Balasubramaniam, S., Chandrasekara, A. I., and Badra Sriyani, H. T. (1980) Planta Med. 39, 66-72.
Raymond-Harriet (1937) C. R. Soc. Biol. 126, 768-770.
Raymond-Hamet (1938) C. R. Acad. Sci. Belg. 207, 1016-1018.
Noamesi, B. K., and Bamgbose, S. O. A. (1980) Planta Med. 39, 51-56.
Noamesi, B. K., and Bamgbose, S. O. A. (1982) Planta Med. 44, 241-245.
Rauwald, H. W., Kober, M., Mutschler, E., and Lambrecht, G. (1992) Planta Med. 58, 486-488.
Bamgbose, S. O. A., and Noamesi, B. K. (1981) Planta Med. 41, 392-396.
Boakye-Yiadom, K., and Heman-Ackah, S. M. (1979) J. Pharm. Sci. 68, 1510-1514.
Paulo, A., Pimentel, M., Viegas, S., Pires, I., Duarte, A., Cabrita, J., and Gomes, E. T. (1994) J. Ethnopharmacol. 44, 73-77.
Paulo, A., Duarte, A., and Gomes, E. T. (1994) J. Ethnopharmacol. 44, 127-130.
Cimanga, K., De Bruyne, T., Lasure, A., Van Poel, B., Pieters, L., Claeys, M., VandenBershe, D., Kambu, K., Tona, L., and Vlietinck, A. J. (1996) Planta Med. 62, 22-27.
Kirby, G. C., Paine, A., Warhurst, D. C., Noamesi, B. K., and Phillipson, J. D. (1995) Phytother. Res. 9, 359-363.
Grellier, P., Ramiaramanana, L., Millerioux, V., Deharo, E., Schrevel, J., Frappier, F., Trigalo, F., Bodo, B., and Pousset, J. L. (1996) Phytother. Res. 10, 317-321.
Wright, C. W., Phillipson, J. D., Awe, S. O., Kirby, G. C., Warhurst, D. C., Quetin-Leclercq, J., and Angenot, L. (1996) Phytother. Res. 10, 361-363.
Cimanga, K., De Bruyne, T., Pieters, L., Vlietinck, A. J., and Turger, C. A. (1997) J. Nat. Prod. 60, 688-691.
Kohn, K. W., Waring, M. J., Glaubiger, D., and Friedman, C. A. (1975) Cancer Res. 35, 71-76.
Fossé, P., Paoletti, C., and Saucier, J. M. (1988) Biochem. Biophys. Res. Commun. 151, 1233-1240.
Le Pecq, J. B., Gosse, C., Dat-Xuong, N. G., Cros, S., and Paoletti, C. (1976) Cancer Res. 36, 3067-3076.
Artega, C. L., Kisner, D. L., Goodman, A., and Von Hoff, D. D. (1987) Eur. J. Cancer Clin. Oncol. 23, 1621-1626.
Bonjean, K., De Pauw-Gillet, M. C., Bassleer, R., Quetin-Leclercq, J., Angenot, L., and Wright, C. W. (1996) Phytother. Res. 10, S159-S160.
Kreuzer, K. N. (1989) Pharmacol. Ther. 43, 377-395.
Capranico, G., and Zunino, F. (1995) Curr. Pharm. Des. 1, 1-14.
Wells, R. D., Larson, J. E., Grant, R. C., Shortle, B. E., and Cantor, C. R. (1970) J. Mol. Biol. 54, 465-497.
Fredericq, E., and Houssier, C. (1973) in Electric Dichroism and Electric Birefringence, Clarendon Press, Oxford.
Houssier, C., and O'Konski, C. T. (1981) in Molecular Electrooptics (Krause, S., Ed.) pp 309-339, Plenum Publishing Corp., New York.
Houssier, C. (1981) in Molecular Electrooptics (Krause, S., Ed.) pp 363-398, Plenum Publishing Corp., New York.
Bailly, C., Hénichart, J.-P., Colson, P., and Houssier, C. (1992) J. Mol. Recognit. 5, 155-171.
Colson, P., Bailly, C., and Houssier, C. (1996) Biophys. Chem. 58, 125-140.
Kerckaert, J.-P., Deweindt, C., Tilly, H., Quief, S., Lecocq, G., and Bastard, C. (1993) Nat. Genet. 5, 66-70.
Bailly, C., and Waring, M. J. (1995) J. Biomol. Struct. Dyn. 12, 869-898.
Mosmann, T. (1983) J. Immunol. Methods 65, 55-63.
Bacus, J. W., and Grace, L. J. (1987) Appl. Opt. 26, 3280-3293.
Taylor, S. R., Titus-Ernstoff, L., and Stitely, S. (1989) Cytometry 10, 382-387.
Cantor, C. R., and Schimmel, P. R. (1980) Biophysical Chemistry, W. H. Freeman and Co., San Francisco.
Wilson, W. R., Baguley, B. C., Wakelin, L. P. G., and Waring, M. J. (1981) Mol. Pharmacol. 20, 404-414.
Houssier, C., Hardy, B., and Fredericq, E. (1974) Biopolymers 13, 1141-1160.
Fredericq, E., and Houssier, C. (1972) Biopolymers 11, 2281-2308.
Bourdouxhe, C., Colson, P., Houssier, C., Sun, J. C., Montenay-Garestier, T., Hélène, C., Rivalle, C., Bisagni, E., Waring, M. J., Hénichart, J.-P., and Bailly, C. (1992) Biochemistry 31, 12385-12396.
Bailly, C., Michaux, C., Colson, P., Houssier, C., Sun, J. S., Garestier, T., Hélène, C., Hénichart, J.-P., Rivalle, C., Bisagni, E., and Waring, M. J. (1994) Biochemistry 33, 15348-15364.
Nordén, B., and Kurucsev, T. (1994) J. Mol. Recognit. 7, 141-156.
Bailly, C., O'Huigin, C., Houssin, R., Colson, P., Houssier, C., Rivalle, C., Bisagni, E., Hénichart, J.-P., and Waring, M. J. (1992) Mol. Pharmacol. 41, 845-855.
Covey, J. M., Kohn, K. W., Kerrigan, D., Tilchen, E. J., and Pommier, Y. (1988) Cancer Res. 48, 860-865.
Nelson, E. M., Tewey, K. M., and Liu, L. F. (1984) Proc. Natl. Acad. Sci. U.S.A. 81, 1361-1365.
Rowe, T. C., Chen, G. L., Hsiang, Y. H., and Liu, L. F. (1986) Cancer Res. 46, 2021-2026.
Tewey, K. M., Chen, G. L., Nelson, E. M., and Liu, L. F. (1984) J. Biol. Chem. 259, 9182-9187.
Fossé, P., René, B., Saucier, J.-M., Nguyen, C. H., Bisagni, E., and Paoletti, C. (1990) Biochem. Pharmacol. 39, 669-676.
Bailly, C., O'Huigin, C., Rivalle, C., Bisagni, E., Hénichart, J.-P., and Waring, M. J. (1990) Nucleic Acids Res. 18, 6283-6291.